Cite
Phase II study of HCVIDD/ MA in patients with newly diagnosed peripheral T-cell lymphoma.
MLA
Chihara, Dai, et al. “Phase II Study of HCVIDD/ MA in Patients with Newly Diagnosed Peripheral T-Cell Lymphoma.” British Journal of Haematology, vol. 171, no. 4, Nov. 2015, pp. 509–16. EBSCOhost, https://doi.org/10.1111/bjh.13628.
APA
Chihara, D., Pro, B., Loghavi, S., Miranda, R. N., Medeiros, L. J., Fanale, M. A., Hagemeister, F. B., Fayad, L. E., Romaguera, J. E., Samaniego, F., Neelapu, S. S., Younes, A., Fowler, N. H., Rodriguez, M. A., Wang, M., Kwak, L. W., McLaughlin, P., Dang, N. H., & Oki, Y. (2015). Phase II study of HCVIDD/ MA in patients with newly diagnosed peripheral T-cell lymphoma. British Journal of Haematology, 171(4), 509–516. https://doi.org/10.1111/bjh.13628
Chicago
Chihara, Dai, Barbara Pro, Sanam Loghavi, Roberto N. Miranda, L. Jeffrey Medeiros, Michelle A. Fanale, Fredrick B. Hagemeister, et al. 2015. “Phase II Study of HCVIDD/ MA in Patients with Newly Diagnosed Peripheral T-Cell Lymphoma.” British Journal of Haematology 171 (4): 509–16. doi:10.1111/bjh.13628.